A detailed history of State Board Of Administration Of Florida Retirement System transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, State Board Of Administration Of Florida Retirement System holds 16,300 shares of RCKT stock, worth $227,874. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,300
Previous 16,300 -0.0%
Holding current value
$227,874
Previous $350,000 14.0%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$20.66 - $26.72 $3,925 - $5,076
-190 Reduced 1.15%
16,300 $350,000
Q1 2024

May 08, 2024

BUY
$26.16 - $30.74 $4,970 - $5,840
190 Added 1.17%
16,490 $444,000
Q4 2023

Feb 09, 2024

BUY
$16.78 - $31.94 $3,523 - $6,707
210 Added 1.31%
16,300 $488,000
Q3 2023

Nov 08, 2023

BUY
$15.07 - $24.05 $2,411 - $3,848
160 Added 1.0%
16,090 $329,000
Q2 2023

Aug 11, 2023

SELL
$16.59 - $23.6 $9,290 - $13,216
-560 Reduced 3.4%
15,930 $316,000
Q4 2022

Feb 07, 2023

SELL
$15.5 - $22.76 $21,855 - $32,091
-1,410 Reduced 7.88%
16,490 $323,000
Q2 2022

Aug 05, 2022

BUY
$7.96 - $16.64 $3,263 - $6,822
410 Added 2.34%
17,900 $246,000
Q4 2021

Feb 08, 2022

BUY
$21.52 - $36.02 $2,711 - $4,538
126 Added 0.73%
17,490 $382,000
Q2 2021

Aug 10, 2021

BUY
$39.41 - $47.25 $92,534 - $110,943
2,348 Added 15.64%
17,364 $769,000
Q1 2021

May 10, 2021

SELL
$43.34 - $65.91 $3,900 - $5,931
-90 Reduced 0.6%
15,016 $666,000
Q4 2020

Feb 08, 2021

SELL
$23.3 - $59.57 $3,728 - $9,531
-160 Reduced 1.05%
15,106 $828,000
Q3 2020

Nov 09, 2020

BUY
$20.5 - $28.59 $13,120 - $18,297
640 Added 4.38%
15,266 $349,000
Q2 2020

Aug 07, 2020

BUY
$13.32 - $22.61 $194,818 - $330,693
14,626 New
14,626 $306,000

Others Institutions Holding RCKT

About ROCKET PHARMACEUTICALS, INC.


  • Ticker RCKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 75,683,696
  • Market Cap $1.06B
  • Description
  • Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...
More about RCKT
Track This Portfolio

Track State Board Of Administration Of Florida Retirement System Portfolio

Follow State Board Of Administration Of Florida Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.